Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01551186 · ClinicalTrials.gov registry record · Phase 4
The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 103
- Enrollment target
NCT01551186 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 103 participants.
The verdict
NCT01551186, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 103 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on a ventilator.
Interventions
- DIETARY_SUPPLEMENT Lactobacillus rhamnosus GG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01551186
The ClinicalTrials.gov registry entry for NCT01551186 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus rhamnosus GG is the first listed.
NCT01551186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01551186 about?
NCT01551186 is a clinical study titled "The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria". The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on a ventilator.
What is the current status of trial NCT01551186?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 103 participants. The study started on 2012-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01551186?
The interventions under investigation include: Lactobacillus rhamnosus GG (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01551186?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.